← Leaderboards
R. Mark Ghobrial
University Of California Los Angeles
$3,459,191
Attributed
$3,459,191
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $604K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,459,191 · 3
By mechanism
R01$2,297,082 · 2
U01$1,162,109 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Judith Cheryl Gasson$28,230,504
- Jeremy Mg Taylor$15,840,467
- Teresa E Seeman$21,772,630
- Lene Levy-Storms$581,718
- Pamela Davidson$717,103
Others in their field
Top investigators on “Transplantation”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Mary M Horowitz · Medical College Of Wisconsin$224,924,548
- Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Richard L Schilsky · University Of Chicago$117,759,216
- Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111
Research focus
TransplantationChronicTissue DonorsTransplant RecipientsLiver TransplantationOrganQuality Of LifeLiver DiseasesSample SizeNatural HistorySiteLifeAdultEnrollmentLiverCohortEvaluationEventAddictionAlcohol Use DisorderAccelerationAlcoholic Liver DiseasesBehavior TherapyAlcoholic Hepatitis
Grant awards (14)
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)$401,203
R01 · FY2025 · AA · contact PI
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)$390,224
R01 · FY2024 · AA · contact PI
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)$324,817
R01 · FY2023 · AA · contact PI
ADLDT: An Opportunity to Expand the National Donor Pool$72,124
U01 · FY2008 · DK · contact PI
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES$253,046
R01 · FY2007 · AI · contact PI
ADLDT: An Opportunity to Expand the National Donor Pool$280,907
U01 · FY2006 · DK · contact PI
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES$260,604
R01 · FY2006 · AI · contact PI
ADLDT: An Opportunity to Expand the National Donor Pool$30,450
U01 · FY2006 · DK · contact PI
ADLDT: An Opportunity to Expand the National Donor Pool$337,125
U01 · FY2005 · DK
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES$266,875
R01 · FY2005 · AI
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES$266,875
R01 · FY2004 · AI
ADLDT: An Opportunity to Expand the National Donor Pool$231,139
U01 · FY2004 · DK
ADLDT: An Opportunity to Expand the National Donor Pool$210,364
U01 · FY2003 · DK
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES$133,438
R01 · FY2003 · AI